An introductory perspective on emerging, transformative technologies in biopharma: promises, challenges and impediments

Abstract

This article provides a top-level overview of some key challenges and potential solutions associated with the development and commercialization of innovative and transformative solutions to address identified needs in biopharmaceutical, MedTech and Digital Health markets. As the industry seeks to incorporate more diverse technologies, it is simultaneously transforming thru the formation of open innovation partnership models and collaborations amongst the various parties in the ecosystem, including start-ups and emerging organizations. Accordingly, organizational, or business model transformation is required to reduce risk, while providing for capital-efficient development, clinical validation, and commercialization. We also address the need for an ethical and transparent approach to align the interests of all parties in the healthcare ecosystem and to achieve affordable pricing of the resultant solutions.